Azria, M.

Salmon calcitonin: a review of current and future therapeutic indications

Chesnut, C. H., Azria, M., Silverman, S., Engelhardt, M., Olson, M., & Mindeholm, L. (2008) · Osteoporosis International

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 216

The myotropic and plasma-calcium modulating effects of calcitonin gene-related peptide (CGRP)

Tippins, J. R., Morris, H. R., Panico, M., Etienne, T., Bevis, P., Girgis, S., MacIntyre, I., Azria, M., & Attinger, M. (1984) · Neuropeptides

Neuropeptides and Animal PhysiologyCardiovascular, Neuropeptides, and Oxidative Stress Research

Cited by 180

Effects of Salmon Calcitonin on Trabecular Microarchitecture as Determined by Magnetic Resonance Imaging: Results From the QUEST Study

Chesnut, C. H., Majumdar, S., Newitt, D. C., Shields, A., Van Pelt, J., Laschansky, E., Azria, M., Kriegman, A., Olson, M., Eriksen, E. F., et al. (2005) · Journal of Bone and Mineral Research

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 163

Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis

Manicourt, D., Azria, M., Mindeholm, L., Thonar, E. J. ‐., & Devogelaer, J. (2006) · Arthritis & Rheumatism

Osteoarthritis Treatment and MechanismsMusculoskeletal pain and rehabilitation

Cited by 135

Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: A new potential treatment of osteoarthritis

Bagger, Y. Z., Tankó, L. B., Alexandersen, P., Karsdal, M. A., Olson, M., Mindeholm, L., Azria, M., & Christiansen, C. (2005) · Bone

Osteoarthritis Treatment and MechanismsBone health and osteoporosis research

Cited by 109